Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes
Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
06/2003
06/18/2003CN1425062A Dioxygenases catalyzing asymetric cleavage of beta-carotene
06/18/2003CN1425023A Transgenic mice containing TRP gene disruptions
06/18/2003CN1424398A Preparation for soya peroxidase
06/18/2003CN1424397A Producing process for extracting allinase from garlic
06/18/2003CN1111601C Mutant ÔÇÿalphaÔÇÖ-amylase
06/18/2003CN1111599C Choline monooxidase gene and method for culturing drought and salinity-resistant plant
06/18/2003CN1111429C Urease-based vaccine against HeIicobacter infection
06/17/2003US6579975 Consensus phytases
06/17/2003US6579974 Acyl CoA:cholesterol acyltransferase (ACAT-2)
06/17/2003US6579973 Compositions for the treatment and diagnosis of breast cancer and methods for their use
06/17/2003US6579972 An antibody having a specific binding affinity to a polypeptide of given amino acid sequence; can use in treating diabetes, skeletal muscle diseases, Alzheimer's disease, or peripheral neuropathies with an agonist or antagonist
06/17/2003US6579969 Purified polypeptide of given amino acid sequence; serine/threonine kinase
06/17/2003US6579903 Klainetins and their derivatives, method for their preparation and use thereof
06/17/2003US6579856 Inhibition of stress activated protein kinase (SAPK) pathway and sensitization of cells to cancer therapies
06/17/2003US6579841 Variant EGIII-like cellulase compositions
06/17/2003US6579710 Human kinases and polynucleotides encoding the same
06/17/2003US6579709 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
06/17/2003US6579708 Human uridine kinase
06/17/2003US6579707 Maintaining performance of enzymatic polypeptide; obtain polypeptide, incubate in zwitterionic buffer, freeze, monitor enzymatic activity
06/17/2003US6579703 Enhanced protein thermostability and temperature resistance
06/17/2003US6579695 Phosphopantetheinyl transferases and uses thereof
06/17/2003US6579693 Comprising nucleic acids encoding human NADPH-cytochrome reductase and human cytochrome; inactivated genes; contacting a chemical compound with an enzyme preparation to determine the metabolites from the degradation of the compound
06/17/2003US6579691 DNA sequence encoding a neuronal protein kinase (NPK) which phosphorylates tau proteins as well as other microtubule associated proteins (MAPs) in positions crucial for the binding to microtubules, alzheimers disease, antitumor
06/17/2003US6579689 Modulation of γ-secretase activity
06/17/2003US6579678 Identifying evolved polynucleotides using recursive sequence recombination; recombining overlapping nucleotide sequences; screening for desired property; use in correlating different combinations of mutations with a desired result
06/17/2003US6579674 Administering antisense VA 1 (ava 1) oligodeoxynucleotides with carrier
06/17/2003US6578315 Accelerated mulching paper degradation process and mulching paper for implementing the process
06/17/2003CA2222128C Surface anchoring vector and system for foreign proteins thereof
06/17/2003CA2096020C 2.beta.,19-methyleneamino bridged steroids as aromatase inhibitors
06/17/2003CA1341432C Variants of plasminogen activators and processes for their production
06/12/2003WO2003048733A2 Undecaprenyl pyrophosphate synthase (upps) enzyme and methods of use
06/12/2003WO2003048378A2 Methods and compositions for selectively cleaving dna containing duplex acids in a complex nucleic acid mixture
06/12/2003WO2003048361A2 P55pik
06/12/2003WO2003048359A1 Markers for sugar/lipid metabolic disorders and utilization thereof
06/12/2003WO2003048354A1 Protein-decomposing/eliminating enzyme and utilization thereof
06/12/2003WO2003048353A1 Polypeptides having protease activity and nucleic acids encoding same
06/12/2003WO2003048352A2 Histone h3 methyltransferase polypeptide
06/12/2003WO2003048351A1 Mutated 6-phosphogluconate dehydrogenase
06/12/2003WO2003048350A1 Regulation of human lactate dehydrogenase
06/12/2003WO2003048349A2 Acetoacetyl-coa thiolase and use of for the identification of novel fungicidal substances
06/12/2003WO2003048345A1 Phenotypic screen of chimeric proteins
06/12/2003WO2003048340A2 Crystal structure of mitogen-activated protein kinase-activated protein kinase 2 and binding pockets thereof
06/12/2003WO2003048330A2 Hyaluronan synthases and methods of making and using same
06/12/2003WO2003048320A2 Novel motor protein of p. falciparum and methods for its use
06/12/2003WO2003048316A2 Polynucleotides encoding novel human mitochondrial and microsomal glycerol-3-phosphate acyl-transferases and variants thereof
06/12/2003WO2003048310A2 Thermus oshimai nucleic acid polymerases
06/12/2003WO2003048309A2 Thermus thermophilus nucleic acid polymerases
06/12/2003WO2003048308A2 Thermus brockianus nucleic acid polymerases
06/12/2003WO2003048307A2 Thermus igniterrae nucleic acid polymerases
06/12/2003WO2003048303A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
06/12/2003WO2003048148A2 Statin-like compounds
06/12/2003WO2003047613A1 Use of c-jun or c-jun activating agents such as uv or c-jun n-terminal kinases (junks) for treating cancer
06/12/2003WO2003047611A2 Ptp10d, tec and edtp involved in triglycerid-metabolism
06/12/2003WO2003047547A2 Prenyltransferase from plants
06/12/2003WO2003047527A2 Variants of adp-glucose pyrophosphorylase affecting phosphate sensitivity and other parameters
06/12/2003WO2003047509A2 Enzyme activity profiles
06/12/2003WO2003047506A2 Peptide agonists of prostate-specific antigen, and uses therefor
06/12/2003WO2003027282A9 Adamts-15, -16, -17, -18 and -19
06/12/2003WO2003020951A3 Identification of a novel group ii intron splicing factor
06/12/2003WO2003018829A3 6299, a human zinc carboxypeptidase family member and uses therefor
06/12/2003WO2003012070A3 Gene associated with bone disorders
06/12/2003WO2002057465A3 Method for producing polyunsaturated fatty acids, novel biosynthesis genes and novel plant expression constructs
06/12/2003WO2002046442A3 Phosphatase stress-related proteins and methods of use in plants
06/12/2003WO2002020758A3 Novel proteins and nucleic acids encoding same
06/12/2003US20030110535 Transforming gene using enzyme; potatoes; discoloration inhibition
06/12/2003US20030110534 Monocotyledon plant cells and plants which synthesise modified starch
06/12/2003US20030110533 Acetyl-CoA carboxylase subunits
06/12/2003US20030110530 Genetic engineered nucleic acids; transformation; resists parasites, nematodes, insects, pests
06/12/2003US20030110520 Isolation and characterization of a N. crassa silencing gene and uses thereof
06/12/2003US20030110169 System and method for providing manageability to security information for secured items
06/12/2003US20030109693 Chondroitin polymerase and DNA encoding the same
06/12/2003US20030109675 Therapy for infections; enzyme inhibitors
06/12/2003US20030109674 Antiinflammatory agents; medical diagnosis; genetic engineered polypeptide
06/12/2003US20030109672 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/12/2003US20030109671 Therapeutic agents and methods of use thereof for the modulation of angiogenesis
06/12/2003US20030109587 Gelling composition
06/12/2003US20030109490 Composite stimulating iNOS enzyme which induce immuno-reactant nitric oxide synthesis and process for preparing the same
06/12/2003US20030109438 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
06/12/2003US20030109423 Cyclin- dependent kinases (Cdks) are important for driving cells through different phases of the cell cycle and their sequential activation and deactivation are tightly regulated activation of the mitotic Cdk, Cdc2, requires multiple events;
06/12/2003US20030109022 Asp2
06/12/2003US20030109021 Polynucleotide encoding a novel metalloprotease highly expressed in the testis, MMP-29
06/12/2003US20030109020 Novel human lysosomal protein and methods of its use
06/12/2003US20030109019 In situ polymerase chain reaction
06/12/2003US20030109017 Chemical and/or biological decontamination system
06/12/2003US20030109014 Process for the fermentative preparation of L-amino acids with amplification of the tkt gene
06/12/2003US20030109013 DNA encoding hydantoinase, DNA encoding N-carbamyl-L-amino acid hydrolase, recombinant DNA, transformed cell, method of producing protein, and method of producing optically active amino acid
06/12/2003US20030109008 Cell proliferation, cell differentiation; stem cells
06/12/2003US20030109007 Process for producing N-acetylneuraminic acid
06/12/2003US20030109005 Sequence determination; polymerase chain reactions
06/12/2003US20030109002 SIRP proteins and uses thereof
06/12/2003US20030108998 Aggrecan degrading metallo proteases
06/12/2003US20030108991 Genetic engineering; keratinase fused to nucleic acid
06/12/2003US20030108988 Thermal tolerant avicelase from acidothermus cellulolyticus
06/12/2003US20030108983 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/12/2003US20030108982 Process for oxidation of steroids and genetically engineered cells used therein
06/12/2003US20030108979 Methods for the identification of inhibitors of threonine synthase as antibiotics
06/12/2003US20030108971 Enzyme
06/12/2003US20030108970 Generating antibodies; quantitative analysis
06/12/2003US20030108966 Antibodies that bind to cancer-associated antigen CD46 and methods of use thereof
06/12/2003US20030108959 Treating diseases mediated by metalloprotease-shed proteins
1 ... 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 ... 1416